The Potential of Fluocinolone Acetonide to Mitigate Inflammation and Lipid Accumulation in 2D and 3D Foam Cell Cultures
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Potential of Fluocinolone Acetonide to Mitigate Inflammation and Lipid Accumulation in 2D and 3D Foam Cell Cultures
Authors
Keywords
-
Journal
Biomed Research International
Volume 2018, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2018-11-23
DOI
10.1155/2018/3739251
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Drug Delivery Systems Tailored for Improved Administration of Glucocorticoids
- (2017) Fred Lühder et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets
- (2016) Joe WE Moss et al. Future Medicinal Chemistry
- Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
- (2015) Dipak P. Ramji et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective
- (2014) Emira Ayroldi et al. FASEB JOURNAL
- Macrophage CD14 expression in human carotid plaques is associated with complicated lesions, correlates with thrombosis, and is reduced by angiotensin receptor blocker treatment
- (2014) Cecilia Hermansson et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages
- (2014) Matthias Bartneck et al. Nanomedicine-Nanotechnology Biology and Medicine
- Cell culture, oxidative stress, and antioxidants: Avoiding pitfalls
- (2014) Barry Halliwell Biomedical Journal
- Fluocinolone acetonide partially restores the mineralization of LPS-stimulated dental pulp cells through inhibition of NF-κB pathway and activation of AP-1 pathway
- (2013) Zhongning Liu et al. BRITISH JOURNAL OF PHARMACOLOGY
- CXCL5 limits macrophage foam cell formation in atherosclerosis
- (2013) Anthony Rousselle et al. JOURNAL OF CLINICAL INVESTIGATION
- Functions of Monocyte Chemotactic Protein-3 in Transgenic Mice Fed a High-Fat, High-Cholesterol Diet
- (2013) So Jung An JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Membrane Glucocorticoid Receptor Activation Induces Proteomic Changes Aligning with Classical Glucocorticoid Effects
- (2013) Sara Vernocchi et al. MOLECULAR & CELLULAR PROTEOMICS
- IL-1 signaling in atherosclerosis: sibling rivalry
- (2013) Frederick J Sheedy et al. NATURE IMMUNOLOGY
- CCL20 Is Increased in Hypercholesterolemic Subjects and Is Upregulated By LDL in Vascular Smooth Muscle Cells
- (2011) Olivier Calvayrac et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Influence of Drug Solubility and Lipophilicity on Transscleral Retinal Delivery of Six Corticosteroids
- (2011) A. Thakur et al. DRUG METABOLISM AND DISPOSITION
- Progress and challenges in translating the biology of atherosclerosis
- (2011) Peter Libby et al. NATURE
- Perspectives and opportunities for nanomedicine in the management of atherosclerosis
- (2011) Mark E. Lobatto et al. NATURE REVIEWS DRUG DISCOVERY
- Anti-inflammatory therapeutics for the treatment of atherosclerosis
- (2011) Israel F. Charo et al. NATURE REVIEWS DRUG DISCOVERY
- Expression of IFN-γ before and after treatment of oral lichen planus with 0.1% fluocinolone acetonide in orabase
- (2009) Pornpan Youngnak-Piboonratanakit et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- How corticosteroids control inflammation: Quintiles Prize Lecture 2005
- (2006) Peter J Barnes BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now